Where should I publish my paper?
Paste your title, abstract or keywords. The finder matches them to research topics and suggests ranked journals that publish most on those topics.
Journals for “Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis”
Suggested journals
Topic match is relative to the best match in this search (100% = best). Under each journal, "Publishes on" shows which of the matched topics it publishes and what share of its recent papers they make up. Fees are shown only where DOAJ records them; "Not recorded" does not mean the journal is free.
| # | Journal | Topic match | ITS Journal Score | Global rank | Papers 2021–2025 | Open access | Fee (APC) | Compare |
|---|---|---|---|---|---|---|---|---|
| 1 | Respiratory Investigation Elsevier BV · The Netherlands Publishes on: Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (23%) | 100% | 69.2 | #7,233 | 767 | 35% | Not recorded | |
| 2 | Respiratory Medicine Case Reports Elsevier BV · The Netherlands · DOAJ Publishes on: Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (20%) | 87% | 57.5 | #14,455 | 1,016 | 100% | US$1,540 | |
| 3 | European Respiratory Review European Respiratory Society · United Kingdom · DOAJ Publishes on: Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (15%) | 65% | 85.2 | #800 | 572 | 100% | 3,640 EUR | |
| 4 | Current Opinion in Pulmonary Medicine Lippincott Williams & Wilkins · United States Publishes on: Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (16%) | 67% | 74.2 | #4,474 | 453 | 25% | Not recorded | |
| 5 | Seminars in Respiratory and Critical Care Medicine Thieme Medical Publishers (Germany) · United States Publishes on: Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (15%) | 64% | 77.3 | #3,167 | 409 | 16% | Not recorded | |
| 6 | American Journal of Respiratory Cell and Molecular Biology American Thoracic Society · United States Publishes on: Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (14%) | 62% | 79.2 | #2,418 | 1,010 | 74% | Not recorded | |
| 7 | Respiratory Research BioMed Central · United Kingdom · DOAJ Publishes on: Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (13%) | 56% | 83.6 | #1,126 | 1,861 | 100% | 3,090 EUR | |
| 8 | BMC Pulmonary Medicine BioMed Central · United Kingdom · DOAJ Publishes on: Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (13%) | 58% | 77.0 | #3,290 | 2,682 | 100% | 2,690 EUR | |
| 9 | Respirology Case Reports Wiley · United Kingdom · DOAJ Publishes on: Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (16%) | 69% | 57.2 | #14,688 | 1,243 | 100% | 1,020 EUR | |
| 10 | Respirology Wiley · Australia Publishes on: Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (13%) | 54% | 77.0 | #3,266 | 2,309 | 60% | Not recorded | |
| 11 | Lung Springer Science+Business Media · Germany Publishes on: Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (12%) | 52% | 76.6 | #3,459 | 451 | 52% | Not recorded | |
| 12 | Clinics in Chest Medicine Elsevier BV · United States Publishes on: Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (13%) | 55% | 70.0 | #6,786 | 450 | 23% | Not recorded | |
| 13 | Advances in respiratory medicine MDPI AG · Poland · DOAJ Publishes on: Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (13%) | 57% | 66.2 | #9,079 | 326 | 100% | 1,300 CHF | |
| 14 | Respiratory Medicine and Research Elsevier BV · France Publishes on: Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (14%) | 62% | 54.3 | #16,550 | 393 | 42% | Not recorded | |
| 15 | European Respiratory Journal European Respiratory Society Publishes on: Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (10%) | 42% | 89.9 | #258 | 2,030 | 68% | Not recorded | |
| 16 | Current Pulmonology Reports Springer Science+Business Media · United States Publishes on: Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (14%) | 59% | 52.3 | #17,839 | 133 | 33% | Not recorded | |
| 17 | Pulmonary Pharmacology & Therapeutics Elsevier BV · United States Publishes on: Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (11%) | 49% | 71.8 | #5,799 | 240 | 32% | Not recorded | |
| 18 | Internal Medicine The Japanese Society of Internal Medicine · Japan Publishes on: Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (12%) | 51% | 67.2 | #8,446 | 3,530 | 100% | Not recorded | |
| 19 | American Journal of Respiratory and Critical Care Medicine American Thoracic Society · United States Publishes on: Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (11%) | 48% | 72.2 | #5,577 | 10,027 | 25% | Not recorded | |
| 20 | BMJ Open Respiratory Research BMJ · United Kingdom · DOAJ Publishes on: Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (10%) | 44% | 72.7 | #5,326 | 823 | 100% | 2,390 GBP | |
| 21 | Annals of the American Thoracic Society American Thoracic Society · United States Publishes on: Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (10%) | 42% | 76.1 | #3,632 | 1,516 | 67% | Not recorded | |
| 22 | CHEST Journal Elsevier BV · United States Publishes on: Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (10%) | 44% | 73.2 | #5,052 | 20,131 | 55% | Not recorded | |
| 23 | The Lancet Respiratory Medicine Elsevier BV · The Netherlands Publishes on: Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (8%) | 34% | 90.0 | #250 | 1,472 | 58% | Not recorded | |
| 24 | The Japanese Journal of Sarcoidosis and Other Granulomatous Disorders Japan Society of Sarcoidosis and other Granulomatous Disorders · Japan Publishes on: Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (16%) | 71% | 20.6 | #51,908 | 99 | 100% | Not recorded | |
| 25 | Case Reports in Pulmonology Hindawi Publishing Corporation · United Kingdom · DOAJ Publishes on: Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (14%) | 60% | 39.3 | #29,125 | 80 | 100% | US$870 | |
| 26 | Respiration Karger Publishers · Switzerland Publishes on: Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (9%) | 41% | 74.2 | #4,494 | 637 | 46% | Not recorded | |
| 27 | Experimental Lung Research Informa · United States · DOAJ Publishes on: Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (11%) | 46% | 63.5 | #10,684 | 113 | 58% | US$2,990 | |
| 28 | Pulmonary Medicine Hindawi Publishing Corporation · United Kingdom · DOAJ Publishes on: Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (12%) | 51% | 54.6 | #16,391 | 55 | 100% | US$1,100 | |
| 29 | Journal of Scleroderma and Related Disorders SAGE Publishing · United Kingdom Publishes on: Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (11%) | 48% | 60.0 | #12,960 | 204 | 100% | Not recorded | |
| 30 | American Journal of Physiology-Lung Cellular and Molecular Physiology American Physical Society · United States Publishes on: Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (8%) | 36% | 80.0 | #2,157 | 790 | 82% | Not recorded |
Before you submit
Use this list as a shortlist, not a decision. For each journal, read its aims and scope and a few recent articles, check its peer-review and fee policy on its own website, and confirm any indexing (Scopus, Web of Science, PubMed) with the indexer itself. Be careful with journals that promise very fast acceptance or that contact you by email asking for papers.
How the ITS Journal Score works
One formula applies to every ranked journal, using open data from OpenAlex: 45% citation impact, 35% h-index and 20% size (papers published 2021–2025). Citation impact is the smaller of the journal's two-year mean citedness and its five-year citations per paper, so a journal whose output collapsed cannot jump to the top on old citations. Each part is half a percentile and half a log-scaled value, so the very top is still separated. Growth and open-access share are shown separately and are not part of the score.
A journal is ranked only if it published at least 50 papers in 2021–2025 and was active in at least five of the last six years. Field rankings compare a journal only with journals in the same field; the field is the OpenAlex field with most of the journal's recent papers, or "Multidisciplinary" when no field has 30% of them.
What this is not: the ITS Journal Score is not a Journal Impact Factor, CiteScore or SJR, and this site does not say whether a journal is indexed in Scopus, Web of Science or PubMed. Always confirm aims and scope, indexing, peer review and fees on the journal's own website before you submit.